Instil Bio Inc —— 季度现金流量表 (NASDAQ:TIL) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 263.57 M237.45 M230.99 M211.77 M203.52 M 负债总额 94.13 M92.54 M99.32 M91.35 M89.66 M 权益总额 169.44 M144.91 M131.67 M120.42 M113.87 M 负债及股东权益总额 263.57 M237.45 M230.99 M211.77 M203.52 M 总债务 84.19 M84.23 M84.42 M84.61 M84.81 M 净债务 75.38 M68.86 M76.73 M78.81 M78.17 M

新闻

核心管线不及预期？宜明昂科盘中跌超15%，创始人田文志：预期年底递交preBLA申请

3500万美元到账后，宜明昂科超20亿美元BD合作终止，创始人田文志：美国临床推进缓慢

Citizens分析师重申Instil Bio股票"市场表现"评级

Citizens analyst reiterates Market Perform rating on Instil Bio stock

Instil Bio终止与ImmuneOnco关于AXN-2510和AXN-27M的许可协议

Instil Bio ends license agreement with ImmuneOnco for AXN-2510 and AXN-27M

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.99%

美国股市上涨；截至收盘道琼斯工业平均指数上涨0.99%

贝尔德将Instil Bio股票评级下调至中性，因AXN-2510项目终止

Baird downgrades Instil Bio stock to Neutral on AXN-2510 discontinuation

Dow Jumps Over 400 Points; US Services Activity Falls In December - Aeva Technologies (NASDAQ:AEVA), Alumis (NASDAQ:ALMS)

Instil Bio股价下跌，子公司终止AXN-2510开发计划